Home

THL Equity Fund VII Investors (inVentiv), L.P.

CIK 1713160 · last filed 2021-05-14

THL Equity Fund VII Investors (inVentiv), L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for SYNH, was dated May 14, 2021. Current disclosed insider exposure totals $27.4M across reported positions. The firm reports its address in Boston, MA. 14 SEC filings were submitted jointly with THL Executive Fund VII, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$27.36M

Companies

2

Total Filings

3

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
C/O THOMAS H LEE PARTNERS, L.P.
100 FEDERAL STREET, 35TH FLOOR
BOSTON, MA 02110
Phone
(617) 227-1050
State of Incorporation
DE
Related Filers
THL Executive Fund VII, L.P. — 14 joint filings, latest 2021-06-09
THOMAS H. LEE ADVISORS, LLC — 14 joint filings, latest 2021-06-09
THL Fund VII Coinvestment Partners, L.P. — 13 joint filings, latest 2021-06-09
Joshua M Nelson — 5 joint filings, latest 2021-05-14
TODD M ABBRECHT — 4 joint filings, latest 2021-05-14
Great-West Investors LP — 4 joint filings, latest 2019-05-30
Putnam Investments Employees' Securities Co III LLC — 4 joint filings, latest 2019-05-30
THL Coinvestment Partners, L.P. — 4 joint filings, latest 2019-05-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Syneos Health, Inc. (SYNH) Delisted Director 5,601,782 $42.98 $240.76M $0 2 2021-05-14
INCR 10%+ Owner 5,048,369 $5.42 $27.36M $0 1 2017-08-03

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-05-14 Syneos Health, Inc. (SYNH) Delisted Grant (A) +28,368 $0 EDGAR
2018-05-29 Syneos Health, Inc. (SYNH) Delisted Grant (A) +65,648 $0 EDGAR
2017-08-03 INCR Grant (A) +34,848 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.